Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2015 1
2016 1
2017 1
2020 1
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America.
Márquez-Cruz M, Díaz-Martínez JP, Soto-Molina H, De Saráchaga AJ, Cervantes-Arriaga A, Llorens-Arenas R, Rodríguez-Violante M. Márquez-Cruz M, et al. Among authors: soto molina h. Expert Rev Pharmacoecon Outcomes Res. 2016;16(1):97-102. doi: 10.1586/14737167.2016.1135740. Epub 2016 Jan 25. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26731410 Review.
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O, Muñoz-Montaño W, Muñiz-Hernández S, Campos S, Catalán R, Soto-Molina H, Guzmán Vázquez S, Díaz-Álvarez O, Martínez-Pacheco V, Turcott JG, Ramos-Ramírez M, Cabrera-Miranda L, Barrón F, Cardona AF. Arrieta O, et al. Among authors: soto molina h. Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021. Front Oncol. 2021. PMID: 33959504 Free PMC article.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
Arrieta O, Catalán R, Guzmán-Vazquez S, Barrón F, Lara-Mejía L, Soto-Molina H, Ramos-Ramírez M, Flores-Estrada D, de la Garza J. Arrieta O, et al. Among authors: soto molina h. BMC Cancer. 2020 Sep 1;20(1):829. doi: 10.1186/s12885-020-07329-8. BMC Cancer. 2020. PMID: 32873256 Free PMC article.
[Economic burden assessment for the management of asthma patients at Mexico's National Institute for Respiratory Diseases].
Cano-Salas MDC, Miguel-Reyes JL, Sánchez-Trejo K, López-Estrada EDC, Salas-Hernández J, Arroyo-Rojas ME, Castañeda-Valdivia M, Escobar-Preciado M, Guzmán-Vázquez S, García-García SR, Soto-Molina H. Cano-Salas MDC, et al. Among authors: soto molina h. Rev Alerg Mex. 2024 Jan 2;71(1):12-22. doi: 10.29262/ram.v71i1.1279. Rev Alerg Mex. 2024. PMID: 38683064 Spanish.